Back

Discussion

31 August 2019 (16:20 - 16:30)
Organised by:
Congress Presentation Part of: Epigenetics: a new pathway to tackle residual risk? Diabetes and the Heart ESC Premium Access ESC Congress 2019

About the speakers

Photo
Professor Ulf Landmesser

Charite University Hospital, Berlin (Germany)

Photo
Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Introduction
Professor U. Landmesser (Berlin, DE)
Slides Video
Presentation thumbnail
Challenges in targeting residual risk in diabetic patients, post ACS
Professor P. Libby (Boston, US)
Slides Video
Presentation thumbnail
BET inhibition, an epigenetic pathway: how could BET inhibition modulate atherothrombotic risk
Professor J. Jukema (Leiden, NL)
Slides Video
Presentation thumbnail
Clinical update on BET inhibition: the patient profile that may benefit from BET inhibition?
Professor K. Ray (London, GB)
Slides Video

Access the full session

Session thumbnail
Epigenetics: a new pathway to tackle residual risk?

The Event

Event poster

ESC Congress 2019

31 August 2019 16:20 CET
You may be interested in
thumbnail
Webinar
Prevention of heart failure in diabetic patients at population level
thumbnail
Congress Session
Diabetes, obesity, and heart failure
thumbnail
Webinar
Diabetes and ACS - enhancing post-discharge outcomes after primary PCI